Eric Coldwell
Stock Analyst at Robert W. Baird
(4.57)
# 1,000
Out of 4,696 analysts
795
Total ratings
58.7%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACH Accendra Health | Downgraded: Hold | $6 → $1.5 | $1.17 | +28.21% | 73 | Aug 11, 2026 | |
| COR Cencora | Maintained: Buy | $339 → $370 | $336.36 | +10.00% | 75 | Aug 6, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $213 → $291 | $291.76 | -0.26% | 71 | Aug 6, 2026 | |
| MCK McKesson | Maintained: Buy | $941 → $1,015 | $924.78 | +9.76% | 78 | Aug 6, 2026 | |
| MDLN Medline | Maintained: Buy | $45 → $42 | $36.30 | +15.70% | 4 | Aug 6, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $15 → $10 | $6.04 | +65.56% | 42 | Aug 5, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $186 → $194 | $159.84 | +21.37% | 71 | Jul 31, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $334 → $352 | $331.66 | +6.13% | 74 | Jul 31, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | $20 → $23 | $18.36 | +25.27% | 15 | Jul 30, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | $249 → $287 | $263.84 | +8.78% | 68 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $236 → $255 | $240.80 | +5.90% | 61 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $547 → $624 | $593.02 | +5.22% | 60 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $252 → $248 | $245.49 | +1.02% | 69 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $97.23 | n/a | 28 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $4.70 | n/a | 6 | May 9, 2014 |
Accendra Health
Aug 11, 2026
Downgraded: Hold
Price Target: $6 → $1.5
Current: $1.17
Upside: +28.21%
Cencora
Aug 6, 2026
Maintained: Buy
Price Target: $339 → $370
Current: $336.36
Upside: +10.00%
Charles River Laboratories International
Aug 6, 2026
Maintained: Buy
Price Target: $213 → $291
Current: $291.76
Upside: -0.26%
McKesson
Aug 6, 2026
Maintained: Buy
Price Target: $941 → $1,015
Current: $924.78
Upside: +9.76%
Medline
Aug 6, 2026
Maintained: Buy
Price Target: $45 → $42
Current: $36.30
Upside: +15.70%
AdaptHealth
Aug 5, 2026
Maintained: Buy
Price Target: $15 → $10
Current: $6.04
Upside: +65.56%
ICON Public Limited Company
Jul 31, 2026
Maintained: Buy
Price Target: $186 → $194
Current: $159.84
Upside: +21.37%
Labcorp Holdings
Jul 31, 2026
Maintained: Buy
Price Target: $334 → $352
Current: $331.66
Upside: +6.13%
Fortrea Holdings
Jul 30, 2026
Maintained: Buy
Price Target: $20 → $23
Current: $18.36
Upside: +25.27%
IQVIA Holdings
Jul 29, 2026
Maintained: Buy
Price Target: $249 → $287
Current: $263.84
Upside: +8.78%
Jul 24, 2026
Maintained: Hold
Price Target: $236 → $255
Current: $240.80
Upside: +5.90%
Jul 24, 2026
Maintained: Hold
Price Target: $547 → $624
Current: $593.02
Upside: +5.22%
May 1, 2026
Maintained: Buy
Price Target: $252 → $248
Current: $245.49
Upside: +1.02%
Apr 18, 2022
Maintained: Hold
Price Target: $110
Current: $97.23
Upside: n/a
May 9, 2014
Rated: Buy
Price Target: $23 → $22
Current: $4.70
Upside: n/a